Video

Dr Marcia Wilson Discusses Quality Measures in the Transition to Value-Based Care

Performance measurement is at the heart of improving healthcare, and part of this transition to value-based payment means creating measures that track the improvements of quality care, said Marcia Wilson, PhD, MBA, senior vice president of quality measurement at The National Quality Forum.

Performance measurement is at the heart of improving healthcare, and part of this transition to value-based payment means creating measures that track the improvements of quality care, said Marcia Wilson, PhD, MBA, senior vice president of quality measurement at The National Quality Forum.

Transcript (slightly modified)

What is the importance of measurement and how has it intensified with the government’s move toward paying for value?

At NQF, National Quality Forum, we think performance measurement is really foundation to improving healthcare. And Centers for Medicare and Medicaid Services, they now have goals of better care, smarter spending and healthier people. And when you look at those goals, which they want to reach through this value-based purchasing by paying providers for the quality of care that’s provided as well as the outcomes that are reached for the patient.

When you look at that goals, it means we need to be able to measure, was the quality of care improved. Did we reduce the costs when we provided that care? Are we providing care efficiently, meaning we’re using resources well. And finally, did we end up with a healthier population? And that’s why performance measure has become more critical than ever as the CMS moves towards value-based purchasing. It means providers will be held increasingly accountable and consumers and purchasers are going to want to know about the value of healthcare that’s being provided.

Related Videos
Robin Glasco, MBA
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program
Hans Lee, MD
Screenshot of an interview with Amir Ali, PharmD, BCOP
Mansi Shah, MD, assistant professor, Rutgers Cancer Institute of New Jersey
 Alvaro Alencar, MD, associate professor of clinical medicine, chief medical officer, University of Miami Sylvester Comprehensive Cancer Center
Divya Gupta, MD
Dr Cesar Davila-Chapa
Matias Sanchez, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo